Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV disease

Area of Science:

• Medical Ethics
• Public Health
• Pharmacology

Background:

• Triple-drug therapy for HIV disease presents adherence challenges for disadvantaged patients.
• Concerns exist that nonadherence may lead to drug resistance, prompting some clinicians to withhold treatment.
• Historical labeling of patients as nonadherent has been stigmatizing and inaccurate.

Observation:

• Nonadherence is widespread across all patient groups and not reliably predictable by patient characteristics.
• Traditional terms like 'noncompliant' imply patient obedience rather than collaborative care.
• Current approaches focus on predicting and correcting nonadherent behavior.

Findings:

• Physicians should shift from predicting/correcting nonadherence to encouraging individualized treatment plans.
• Active patient participation in developing treatment strategies can improve medication adherence.
• Balancing public health concerns (drug resistance) with patient rights is essential.

Implications:

• Deemphasizing judgmental assessments of patient behavior fosters trust and respect.
• Individualized HIV treatment plans can enhance medication adherence and patient outcomes.
• Promoting patient-centered care is vital for managing chronic diseases like HIV.